Temova Žane, Roškar Robert
Department of Biopharmacy and Pharmacokinetics, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
Eur J Hosp Pharm. 2017 Mar;24(2):115-119. doi: 10.1136/ejhpharm-2016-000895. Epub 2016 May 6.
The aim of this study was to evaluate the effect of storage conditions on the shelf life of liquid pharmaceuticals with vitamin D in order to determine appropriate storage conditions and shelf life after the product has been opened. Manufacturers rarely specify the shelf life after products have been opened, which leads to a controversial debate among medical professionals regarding the safety of products after opening and optimal storage conditions and considerably different recommendations to the public.
Effect of storage conditions on the shelf life was evaluated by comparing the isothermal stability of vitamin D in three prescription and three non-prescription medicines at different temperatures (4°C, 25°C and 40°C) using stability-indicating high performance liquid chromatography assay.
Most of the examined preparations had a higher vitamin D content than the label claim when the products were first opened, presumably to compensate for loss during production and storage. An association was observed between the initial vitamin D content and its stability in the preparations. The vitamin D overage in liquid prescription medicines guaranteed its content >90% of the amount claimed on the label for at least 1 year when stored at 25°C and for 4 months at 40°C. All tested preparations are consumed when used as recommended over this period. Since some manufacturers recommend storage below room temperature, redefining the storage conditions is of practical significance.
The shelf life after opening examined prescription medicines containing vitamin D as their main active ingredient is at least 1 year at room temperature.
本研究旨在评估储存条件对含维生素D液体制剂保质期的影响,以确定产品开封后的适宜储存条件和保质期。制造商很少规定产品开封后的保质期,这导致医学专业人员之间就是否安全、最佳储存条件展开了争论,给公众的建议也大不相同。
采用稳定性指示高效液相色谱法,比较三种处方药和三种非处方药中维生素D在不同温度(4℃、25℃和40℃)下的等温稳定性,评估储存条件对保质期的影响。
大多数受试制剂在首次开封时维生素D含量高于标签标示量,这可能是为了补偿生产和储存过程中的损失。观察到初始维生素D含量与其在制剂中的稳定性之间存在关联。液体制剂中的维生素D过量保证了在25℃储存时其含量至少在1年内、40℃储存时4个月内保持在标签标示量的90%以上。在此期间按推荐使用,所有受试制剂均可用完。由于一些制造商建议在室温以下储存,因此重新定义储存条件具有实际意义。
以维生素D为主要活性成分的受试处方药开封后的保质期在室温下至少为1年。